A Rationale for Adjuvant Surgical Intervention in Pyoderma Gangrenosum

Medical specialists who care for patients with pyoderma gangrenosum have been reluctant traditionally to consult plastic surgeons. This is the result of previous negative experience with debridement and skin grafting. However, a new understanding of the pathophysiology of the disease process, and better therapeutic options for control have emerged. Very few studies report the results of surgical therapy of this disease, and fewer yet report successful outcome. The authors present their limited experience at the American University of Beirut with 4 patients who were controlled medically followed by skin grafting their large wounds, thus decreasing their morbidity and hospital stay. A review of the literature together with insights on the rationale and timing of surgery in this particular small group of patients are discussed.

[1]  S. Kárpáti,et al.  Wegener's granulomatosis presenting as pyoderma gangrenosum , 2003, International journal of dermatology.

[2]  J. Wang-Rodriguez,et al.  Pyoderma gangrenosum twice complicating percutaneous intervention in a single patient. , 1999, AJR. American journal of roentgenology.

[3]  R. Marsden,et al.  Split skin grafts in the treatment of pyoderma gangrenosum. A report of four cases. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  Finn,et al.  Pyoderma gangrenosum in a child with congenital partial deficiency of leucocyte adherence glycoproteins , 1998, The British journal of dermatology.

[5]  M. Petri,et al.  The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. , 1998, Archives of dermatology.

[6]  H. Petty,et al.  Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. , 1998, The Journal of investigative dermatology.

[7]  H. Petty,et al.  Aberrant Integrin (CR4;αxβ2; CD11c/CD18) Oscillations on Neutrophils in a Mild Form of Pyoderma Gangrenosum , 1998 .

[8]  R. Havlik,et al.  Pyoderma gangrenosum of the breast: sequential grafting. , 1998, Plastic and reconstructive surgery.

[9]  R. D'Incà,et al.  Tacrolimus To Treat Pyoderma Gangrenosum Resistant to Cyclosporine , 1998, Annals of Internal Medicine.

[10]  H. Schuppe,et al.  Topical tacrolimus for pyoderma gangrenosum , 1998, The Lancet.

[11]  H. Petty,et al.  Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum. , 1998, The Journal of investigative dermatology.

[12]  P. Driesch,et al.  Pyoderma gangrenosum: a report of 44 cases with follow‐up , 1997, The British journal of dermatology.

[13]  J. Byrne,et al.  Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. , 1997, Postgraduate medical journal.

[14]  M. Heenen,et al.  A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. , 1997, Dermatology.

[15]  A. Teitel Treatment of pyoderma gangrenosum with methotrexate. , 1996, Cutis.

[16]  W. Su,et al.  Pyoderma gangrenosum: classification and management. , 1996, Journal of the American Academy of Dermatology.

[17]  L. Yu,et al.  'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis. , 1995, Gut.

[18]  C. Samlaska,et al.  Treatment of pyoderma gangrenosum with 4% cromolyn. , 1994, Archives of dermatology.

[19]  V. Goulden,et al.  Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria , 1994, Clinical and experimental dermatology.

[20]  D. V. van Thiel,et al.  Resolution of Severe Pyoderma Gangrenosum in a Patient with Streaking Leukocyte Factor Disease after Treatment with Tacrolimus (FK 506) , 1993, Annals of Internal Medicine.

[21]  J. Petro,et al.  Cyclosporine for Pyoderma Gangrenosum , 1993, Plastic and reconstructive surgery.

[22]  C. Griffiths,et al.  Treatment of pyoderma gangrenosum with cyclosporine. , 1992, Archives of dermatology.

[23]  J. Jessop,et al.  Minimizing the risk of post‐operative pyoderma gangrenosum , 1992, The British journal of dermatology.

[24]  R. Figlin,et al.  Bullous pyoderma gangrenosum after granulocyte colony‐stimulating factor treatment , 1991, Cancer.

[25]  A. Hastings,et al.  Sweet's syndrome progressing to pyoderma gangrenosum—a spectrum of neutrophilic skin disease in association with cryptogenic cirrhosis , 1991, Clinical and experimental dermatology.

[26]  A. Paller,et al.  Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome. , 1990, The Journal of pediatrics.

[27]  J. Callen,et al.  Pyoderma gangrenosum and related disorders. , 1989, Advances in dermatology.

[28]  G. Lazarus,et al.  Present status of pyoderma gangrenosum. Review of 21 cases. , 1989, Archives of dermatology.

[29]  R. Dowden Skin grafting of pyoderma gangrenosum lesions. , 1987, Plastic and Reconstructive Surgery.

[30]  D. Jc,et al.  Pyoderma gangrenosum: skin grafting after preparation with hyperbaric oxygen. , 1987 .

[31]  T. K. Hunt,et al.  Pyoderma Gangrenosum: Skin Grafting after Preparation with Hyperbaric Oxygen , 1987, Plastic and reconstructive surgery.

[32]  H. Zarem,et al.  PYODERMA GANGRENOSUM: RECOGNITION AND MANAGEMENT , 1978, Plastic and reconstructive surgery.